MedPath

Humoral responses to SARS-CoV-2 infection in childre

Recruiting
Conditions
SARS-CoV in children
Registration Number
NL-OMON27267
Lead Sponsor
Stichting Steun Emma
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
420
Inclusion Criteria

Children younger than 18 years of age

Exclusion Criteria

No written informed consent from parents/ guardians or eligible child older than 12 years of age.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
At the end of the study (april 2021) we will assess the following primary outcomes<br>Blood :<br>Neutralizing antibodies (via neutralization assay)<br>IgG and IgM against SARS-CoV2 (via ELISA)<br>Saliva:<br>Secretory total IgA and specific secretory IgA against SARS-CoV2 (via ELISA)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath